-
Je něco špatně v tomto záznamu ?
Altered Steroidome in Women with Gestational Diabetes Mellitus: Focus on Neuroactive and Immunomodulatory Steroids from the 24th Week of Pregnancy to Labor
L. Ondřejíková, A. Pařízek, P. Šimják, D. Vejražková, M. Velíková, K. Anderlová, M. Vosátková, H. Krejčí, M. Koucký, R. Kancheva, M. Dušková, M. Vaňková, J. Bulant, M. Hill
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
34944390
DOI
10.3390/biom11121746
Knihovny.cz E-zdroje
- MeSH
- 20-hydroxysteroid dehydrogenasy metabolismus MeSH
- chromatografie plynová MeSH
- cytochrom P-450 CYP3A metabolismus MeSH
- druhý trimestr těhotenství metabolismus MeSH
- gestační diabetes metabolismus MeSH
- lidé MeSH
- metabolomika metody MeSH
- oxidoreduktasy metabolismus MeSH
- steroid-17-alfa-hydroxylasa metabolismus MeSH
- steroidy analýza MeSH
- tandemová hmotnostní spektrometrie MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Gestational diabetes mellitus (GDM) is a complication in pregnancy, but studies focused on the steroidome in patients with GDM are not available in the public domain. This article evaluates the steroidome in GDM+ and GDM- women and its changes from 24 weeks (± of gestation) to labor. The study included GDM+ (n = 44) and GDM- women (n = 33), in weeks 24-28, 30-36 of gestation and at labor and mixed umbilical blood after delivery. Steroidomic data (101 steroids quantified by GC-MS/MS) support the concept that the increasing diabetogenic effects with the approaching term are associated with mounting progesterone levels. The GDM+ group showed lower levels of testosterone (due to reduced AKR1C3 activity), estradiol (due to a shift from the HSD17B1 towards HSD17B2 activity), 7-oxygenated androgens (competing with cortisone for HSD11B1 and shifting the balance from diabetogenic cortisol towards the inactive cortisone), reduced activities of SRD5As, and CYP17A1 in the hydroxylase but higher CYP17A1 activity in the lyase step. With the approaching term, the authors found rising activities of CYP3A7, AKR1C1, CYP17A1 in its hydroxylase step, but a decline in its lyase step, rising conjugation of neuroinhibitory and pregnancy-stabilizing steroids and weakening AKR1D1 activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011903
- 003
- CZ-PrNML
- 005
- 20220506131324.0
- 007
- ta
- 008
- 220425s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom11121746 $2 doi
- 035 __
- $a (PubMed)34944390
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Ondřejíková, Leona $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 245 10
- $a Altered Steroidome in Women with Gestational Diabetes Mellitus: Focus on Neuroactive and Immunomodulatory Steroids from the 24th Week of Pregnancy to Labor / $c L. Ondřejíková, A. Pařízek, P. Šimják, D. Vejražková, M. Velíková, K. Anderlová, M. Vosátková, H. Krejčí, M. Koucký, R. Kancheva, M. Dušková, M. Vaňková, J. Bulant, M. Hill
- 520 9_
- $a Gestational diabetes mellitus (GDM) is a complication in pregnancy, but studies focused on the steroidome in patients with GDM are not available in the public domain. This article evaluates the steroidome in GDM+ and GDM- women and its changes from 24 weeks (± of gestation) to labor. The study included GDM+ (n = 44) and GDM- women (n = 33), in weeks 24-28, 30-36 of gestation and at labor and mixed umbilical blood after delivery. Steroidomic data (101 steroids quantified by GC-MS/MS) support the concept that the increasing diabetogenic effects with the approaching term are associated with mounting progesterone levels. The GDM+ group showed lower levels of testosterone (due to reduced AKR1C3 activity), estradiol (due to a shift from the HSD17B1 towards HSD17B2 activity), 7-oxygenated androgens (competing with cortisone for HSD11B1 and shifting the balance from diabetogenic cortisol towards the inactive cortisone), reduced activities of SRD5As, and CYP17A1 in the hydroxylase but higher CYP17A1 activity in the lyase step. With the approaching term, the authors found rising activities of CYP3A7, AKR1C1, CYP17A1 in its hydroxylase step, but a decline in its lyase step, rising conjugation of neuroinhibitory and pregnancy-stabilizing steroids and weakening AKR1D1 activity.
- 650 _2
- $a 20-hydroxysteroid dehydrogenasy $x metabolismus $7 D015089
- 650 _2
- $a chromatografie plynová $7 D002849
- 650 _2
- $a cytochrom P-450 CYP3A $x metabolismus $7 D051544
- 650 _2
- $a gestační diabetes $x metabolismus $7 D016640
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolomika $x metody $7 D055432
- 650 _2
- $a oxidoreduktasy $x metabolismus $7 D010088
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a druhý trimestr těhotenství $x metabolismus $7 D011262
- 650 _2
- $a steroid-17-alfa-hydroxylasa $x metabolismus $7 D013254
- 650 _2
- $a steroidy $x analýza $7 D013256
- 650 _2
- $a tandemová hmotnostní spektrometrie $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pařízek, Antonín $u Department of Gynecology and Obstetrics, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Šimják, Patrik $u Department of Gynecology and Obstetrics, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Vejražková, Daniela $u Institute of Endocrinology, 116 94 Prague, Czech Republic $1 https://orcid.org/0000000327992874
- 700 1_
- $a Velíková, Marta $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 700 1_
- $a Anderlová, Kateřina $u Department of Gynecology and Obstetrics, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Vosátková, Michala $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 700 1_
- $a Krejčí, Hana $u Department of Gynecology and Obstetrics, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Koucký, Michal $u Department of Gynecology and Obstetrics, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Kancheva, Radmila $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 700 1_
- $a Dušková, Michaela $u Institute of Endocrinology, 116 94 Prague, Czech Republic $1 https://orcid.org/0000000247811447 $7 xx0080454
- 700 1_
- $a Vaňková, Markéta $u Institute of Endocrinology, 116 94 Prague, Czech Republic $1 https://orcid.org/0000000318837274
- 700 1_
- $a Bulant, Josef $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 700 1_
- $a Hill, Martin $u Institute of Endocrinology, 116 94 Prague, Czech Republic
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 12 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34944390 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131316 $b ABA008
- 999 __
- $a ok $b bmc $g 1789483 $s 1163104
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 12 $e 20211123 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- LZP __
- $a Pubmed-20220425